Approvals/TGA/DBL Octreotide Injection (octreotide) 0.05 mg/1mL injection solution vial

Approved

STANDARD

DBL Octreotide Injection (octreotide) 0.05 mg/1mL injection solution vial

Pfizer Australia Pty Ltd🇦🇺 Therapeutic Goods Administration

Approval Id: af766f5f5223bb00
Product Name: DBL Octreotide Injection (octreotide) 0.05 mg/1mL injection solution vial
Artg Id: 381260
Artg Name: DBL Octreotide Injection (octreotide) 0.05 mg/1mL injection solution vial
Sponsor: Pfizer Australia Pty Ltd
Company Detail Path: /organization/pfizer-australia-pty-ltd
Artg Date: 2021-12-22
Registration Type: Medicine
Therapeutic Good Type: Medicine
Licence Status: A
Licence Category: LIE

Approved

Agency

TGA

Country

🇦🇺

Approval Date

May 30, 2025

Approval ID

af766f5f5223bb00

Type

Standard